HEADER FLUORESCENT PROTEIN 19-FEB-10 3LVC TITLE CRYSTAL STRUCTURE OF GFP-LIKE PROTEIN ACEGFP_G222E (A. COERULESCENS). TITLE 2 COLORLESS FORM. COMPND MOL_ID: 1; COMPND 2 MOLECULE: GREEN FLUORESCENT PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AEQUOREA COERULESCENS; SOURCE 3 ORGANISM_TAXID: 210840; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE30 KEYWDS COLORLESS GFP-LIKE PROTEIN, CHROMOPHORE BIOSYNTHESIS, FLUORESCENT KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.V.PLETNEVA,V.Z.PLETNEV,S.V.PLETNEV REVDAT 5 15-NOV-23 3LVC 1 REMARK LINK ATOM REVDAT 4 13-OCT-21 3LVC 1 REMARK SEQADV LINK REVDAT 3 08-NOV-17 3LVC 1 REMARK REVDAT 2 09-JUN-10 3LVC 1 JRNL REVDAT 1 09-MAR-10 3LVC 0 JRNL AUTH N.V.PLETNEVA,V.Z.PLETNEV,K.A.LUKYANOV,N.G.GURSKAYA, JRNL AUTH 2 E.A.GORYACHEVA,V.I.MARTYNOV,A.WLODAWER,Z.DAUTER,S.PLETNEV JRNL TITL STRUCTURAL EVIDENCE FOR A DEHYDRATED INTERMEDIATE IN GREEN JRNL TITL 2 FLUORESCENT PROTEIN CHROMOPHORE BIOSYNTHESIS. JRNL REF J.BIOL.CHEM. V. 285 15978 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20220148 JRNL DOI 10.1074/JBC.M109.092320 REMARK 2 REMARK 2 RESOLUTION. 1.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 168358 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.139 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.156 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1687 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.6860 - 2.6090 1.00 14453 136 0.1610 0.1800 REMARK 3 2 2.6090 - 2.0710 1.00 14032 152 0.1320 0.1420 REMARK 3 3 2.0710 - 1.8090 1.00 13957 151 0.1190 0.1370 REMARK 3 4 1.8090 - 1.6440 1.00 13880 141 0.1120 0.1430 REMARK 3 5 1.6440 - 1.5260 1.00 13863 138 0.1040 0.1190 REMARK 3 6 1.5260 - 1.4360 1.00 13847 126 0.1090 0.1270 REMARK 3 7 1.4360 - 1.3640 1.00 13822 133 0.1120 0.1460 REMARK 3 8 1.3640 - 1.3050 1.00 13787 136 0.1220 0.1320 REMARK 3 9 1.3050 - 1.2550 1.00 13750 149 0.1280 0.1660 REMARK 3 10 1.2550 - 1.2110 1.00 13795 122 0.1450 0.1410 REMARK 3 11 1.2110 - 1.1730 1.00 13752 137 0.1550 0.1720 REMARK 3 12 1.1730 - 1.1400 1.00 13733 166 0.1670 0.1740 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 54.48 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.080 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.52300 REMARK 3 B22 (A**2) : -0.58400 REMARK 3 B33 (A**2) : -0.55400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3915 REMARK 3 ANGLE : 1.384 5341 REMARK 3 CHIRALITY : 0.121 580 REMARK 3 PLANARITY : 0.007 698 REMARK 3 DIHEDRAL : 16.780 1498 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LVC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057776. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 169399 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.140 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS 25% PEG 3350, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.93650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.89800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.19350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.89800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.93650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.19350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 230 REMARK 465 HIS A 231 REMARK 465 GLY A 232 REMARK 465 MET A 233 REMARK 465 ASP A 234 REMARK 465 GLU A 235 REMARK 465 LEU A 236 REMARK 465 TYR A 237 REMARK 465 LYS A 238 REMARK 465 THR B 230 REMARK 465 HIS B 231 REMARK 465 GLY B 232 REMARK 465 MET B 233 REMARK 465 ASP B 234 REMARK 465 GLU B 235 REMARK 465 LEU B 236 REMARK 465 TYR B 237 REMARK 465 LYS B 238 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C LEU B 64 N1 GYS B 65 1.36 REMARK 500 C LEU A 64 N1 GYS A 65 1.36 REMARK 500 OD1 ASP A 180 O HOH A 417 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 119 CA - CB - CG ANGL. DEV. = -18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 103 -158.68 -153.13 REMARK 500 ASP B 103 -157.02 -155.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 239 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 239 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 240 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 241 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 242 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LVA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GFP-LIKE PROTEIN ACEGFP (A. COERULESCENS) REMARK 900 RELATED ID: 3LVD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GFP-LIKE PROTEIN ACEGFP_G222E (A. COERULESCENS) REMARK 900 . UV-PHOTOCONVERTED GREEN FORM. DBREF 3LVC A 1 238 UNP Q6YGZ0 Q6YGZ0_9CNID 1 238 DBREF 3LVC B 1 238 UNP Q6YGZ0 Q6YGZ0_9CNID 1 238 SEQADV 3LVC ILE A 11 UNP Q6YGZ0 VAL 11 ENGINEERED MUTATION SEQADV 3LVC LEU A 64 UNP Q6YGZ0 TYR 64 ENGINEERED MUTATION SEQADV 3LVC GLU A 101 UNP Q6YGZ0 LYS 101 ENGINEERED MUTATION SEQADV 3LVC ALA A 206 UNP Q6YGZ0 THR 206 ENGINEERED MUTATION SEQADV 3LVC ILE B 11 UNP Q6YGZ0 VAL 11 ENGINEERED MUTATION SEQADV 3LVC LEU B 64 UNP Q6YGZ0 TYR 64 ENGINEERED MUTATION SEQADV 3LVC GLU B 101 UNP Q6YGZ0 LYS 101 ENGINEERED MUTATION SEQADV 3LVC ALA B 206 UNP Q6YGZ0 THR 206 ENGINEERED MUTATION SEQRES 1 A 236 MET SER LYS GLY ALA GLU LEU PHE THR GLY ILE VAL PRO SEQRES 2 A 236 ILE LEU ILE GLU LEU ASN GLY ASP VAL ASN GLY HIS LYS SEQRES 3 A 236 PHE SER VAL SER GLY GLU GLY GLU GLY ASP ALA THR TYR SEQRES 4 A 236 GLY LYS LEU THR LEU LYS PHE ILE CYS THR THR GLY LYS SEQRES 5 A 236 LEU PRO VAL PRO TRP PRO THR LEU VAL THR THR LEU GYS SEQRES 6 A 236 VAL GLN CYS PHE SER ARG TYR PRO ASP HIS MET LYS GLN SEQRES 7 A 236 HIS ASP PHE PHE LYS SER ALA MET PRO GLU GLY TYR ILE SEQRES 8 A 236 GLN GLU ARG THR ILE PHE PHE GLU ASP ASP GLY ASN TYR SEQRES 9 A 236 LYS SER ARG ALA GLU VAL LYS PHE GLU GLY ASP THR LEU SEQRES 10 A 236 VAL ASN ARG ILE GLU LEU THR GLY THR ASP PHE LYS GLU SEQRES 11 A 236 ASP GLY ASN ILE LEU GLY ASN LYS MET GLU TYR ASN TYR SEQRES 12 A 236 ASN ALA HIS ASN VAL TYR ILE MET THR ASP LYS ALA LYS SEQRES 13 A 236 ASN GLY ILE LYS VAL ASN PHE LYS ILE ARG HIS ASN ILE SEQRES 14 A 236 GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR GLN GLN SEQRES 15 A 236 ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU PRO ASP SEQRES 16 A 236 ASN HIS TYR LEU SER THR GLN SER ALA LEU SER LYS ASP SEQRES 17 A 236 PRO ASN GLU LYS ARG ASP HIS MET ILE TYR PHE GLU PHE SEQRES 18 A 236 VAL THR ALA ALA ALA ILE THR HIS GLY MET ASP GLU LEU SEQRES 19 A 236 TYR LYS SEQRES 1 B 236 MET SER LYS GLY ALA GLU LEU PHE THR GLY ILE VAL PRO SEQRES 2 B 236 ILE LEU ILE GLU LEU ASN GLY ASP VAL ASN GLY HIS LYS SEQRES 3 B 236 PHE SER VAL SER GLY GLU GLY GLU GLY ASP ALA THR TYR SEQRES 4 B 236 GLY LYS LEU THR LEU LYS PHE ILE CYS THR THR GLY LYS SEQRES 5 B 236 LEU PRO VAL PRO TRP PRO THR LEU VAL THR THR LEU GYS SEQRES 6 B 236 VAL GLN CYS PHE SER ARG TYR PRO ASP HIS MET LYS GLN SEQRES 7 B 236 HIS ASP PHE PHE LYS SER ALA MET PRO GLU GLY TYR ILE SEQRES 8 B 236 GLN GLU ARG THR ILE PHE PHE GLU ASP ASP GLY ASN TYR SEQRES 9 B 236 LYS SER ARG ALA GLU VAL LYS PHE GLU GLY ASP THR LEU SEQRES 10 B 236 VAL ASN ARG ILE GLU LEU THR GLY THR ASP PHE LYS GLU SEQRES 11 B 236 ASP GLY ASN ILE LEU GLY ASN LYS MET GLU TYR ASN TYR SEQRES 12 B 236 ASN ALA HIS ASN VAL TYR ILE MET THR ASP LYS ALA LYS SEQRES 13 B 236 ASN GLY ILE LYS VAL ASN PHE LYS ILE ARG HIS ASN ILE SEQRES 14 B 236 GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR GLN GLN SEQRES 15 B 236 ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU PRO ASP SEQRES 16 B 236 ASN HIS TYR LEU SER THR GLN SER ALA LEU SER LYS ASP SEQRES 17 B 236 PRO ASN GLU LYS ARG ASP HIS MET ILE TYR PHE GLU PHE SEQRES 18 B 236 VAL THR ALA ALA ALA ILE THR HIS GLY MET ASP GLU LEU SEQRES 19 B 236 TYR LYS MODRES 3LVC GYS A 65 SER MODRES 3LVC GYS A 65 TYR MODRES 3LVC GYS A 65 GLY MODRES 3LVC GYS B 65 SER MODRES 3LVC GYS B 65 TYR MODRES 3LVC GYS B 65 GLY HET GYS A 65 21 HET GYS B 65 21 HET GOL A 239 6 HET GOL B 239 6 HET GOL B 240 6 HET GOL B 241 6 HET GOL B 242 12 HETNAM GYS [(4Z)-2-(1-AMINO-2-HYDROXYETHYL)-4-(4- HETNAM 2 GYS HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1- HETNAM 3 GYS YL]ACETIC ACID HETNAM GOL GLYCEROL HETSYN GYS CHROMOPHORE (SER-TYR-GLY) HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 GYS 2(C14 H15 N3 O5) FORMUL 3 GOL 5(C3 H8 O3) FORMUL 8 HOH *486(H2 O) HELIX 1 1 LYS A 3 THR A 9 5 7 HELIX 2 2 PRO A 56 VAL A 61 5 6 HELIX 3 3 VAL A 68 SER A 72 5 5 HELIX 4 4 PRO A 75 HIS A 81 5 7 HELIX 5 5 ASP A 82 ALA A 87 1 6 HELIX 6 6 LYS A 156 ASN A 159 5 4 HELIX 7 7 LYS B 3 THR B 9 5 7 HELIX 8 8 PRO B 56 VAL B 61 5 6 HELIX 9 9 VAL B 68 SER B 72 5 5 HELIX 10 10 PRO B 75 HIS B 81 5 7 HELIX 11 11 ASP B 82 ALA B 87 1 6 HELIX 12 12 LYS B 156 ASN B 159 5 4 SHEET 1 A12 VAL A 12 VAL A 22 0 SHEET 2 A12 HIS A 25 ASP A 36 -1 O PHE A 27 N GLY A 20 SHEET 3 A12 LYS A 41 CYS A 48 -1 O LYS A 41 N ASP A 36 SHEET 4 A12 HIS A 217 ALA A 228 -1 O TYR A 220 N LEU A 44 SHEET 5 A12 HIS A 199 SER A 208 -1 N SER A 202 O THR A 225 SHEET 6 A12 HIS A 148 ASP A 155 -1 N HIS A 148 O THR A 203 SHEET 7 A12 GLY A 160 ASN A 170 -1 O GLY A 160 N ASP A 155 SHEET 8 A12 VAL A 176 PRO A 187 -1 O HIS A 181 N PHE A 165 SHEET 9 A12 TYR A 92 PHE A 100 -1 N ILE A 93 O THR A 186 SHEET 10 A12 ASN A 105 GLU A 115 -1 O TYR A 106 N ILE A 98 SHEET 11 A12 THR A 118 THR A 128 -1 O VAL A 120 N LYS A 113 SHEET 12 A12 VAL A 12 VAL A 22 1 N ASP A 21 O GLY A 127 SHEET 1 B12 VAL B 12 VAL B 22 0 SHEET 2 B12 HIS B 25 ASP B 36 -1 O PHE B 27 N GLY B 20 SHEET 3 B12 LYS B 41 CYS B 48 -1 O LYS B 41 N ASP B 36 SHEET 4 B12 HIS B 217 ALA B 228 -1 O TYR B 220 N LEU B 44 SHEET 5 B12 HIS B 199 SER B 208 -1 N SER B 202 O THR B 225 SHEET 6 B12 HIS B 148 ASP B 155 -1 N HIS B 148 O THR B 203 SHEET 7 B12 GLY B 160 ASN B 170 -1 O GLY B 160 N ASP B 155 SHEET 8 B12 VAL B 176 PRO B 187 -1 O HIS B 181 N PHE B 165 SHEET 9 B12 TYR B 92 PHE B 100 -1 N ILE B 93 O THR B 186 SHEET 10 B12 ASN B 105 GLU B 115 -1 O TYR B 106 N ILE B 98 SHEET 11 B12 THR B 118 THR B 128 -1 O VAL B 120 N LYS B 113 SHEET 12 B12 VAL B 12 VAL B 22 1 N GLU B 17 O ILE B 123 LINK C3 GYS A 65 N VAL A 68 1555 1555 1.31 LINK C3 GYS B 65 N VAL B 68 1555 1555 1.33 CISPEP 1 MET A 88 PRO A 89 0 5.40 CISPEP 2 MET B 88 PRO B 89 0 9.87 SITE 1 AC1 7 HIS A 148 ASN A 149 LYS A 166 ARG A 168 SITE 2 AC1 7 HOH A 261 HOH A 347 HOH B 271 SITE 1 AC2 8 HIS B 148 ASN B 149 LYS B 166 ARG B 168 SITE 2 AC2 8 HOH B 260 HOH B 263 HOH B 406 HOH B 445 SITE 1 AC3 10 LYS A 166 ASP A 180 TYR A 182 GLU B 95 SITE 2 AC3 10 ARG B 96 THR B 97 TYR B 182 GLN B 184 SITE 3 AC3 10 HOH B 304 HOH B 414 SITE 1 AC4 7 LYS B 107 SER B 108 ARG B 109 GLU B 124 SITE 2 AC4 7 LEU B 125 THR B 126 HOH B 460 SITE 1 AC5 9 PRO A 89 PHE A 114 GLU A 115 GLY A 116 SITE 2 AC5 9 LYS B 52 LYS B 214 ASP B 216 HOH B 249 SITE 3 AC5 9 HOH B 293 CRYST1 59.873 80.387 95.796 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016702 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012440 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010439 0.00000